DK0507187T3 - Fremgangsmåde til hæmning af pulmonær oxygentoksicitet - Google Patents

Fremgangsmåde til hæmning af pulmonær oxygentoksicitet

Info

Publication number
DK0507187T3
DK0507187T3 DK92105035.7T DK92105035T DK0507187T3 DK 0507187 T3 DK0507187 T3 DK 0507187T3 DK 92105035 T DK92105035 T DK 92105035T DK 0507187 T3 DK0507187 T3 DK 0507187T3
Authority
DK
Denmark
Prior art keywords
oxygen toxicity
inhibiting pulmonary
pulmonary oxygen
inhibiting
toxicity
Prior art date
Application number
DK92105035.7T
Other languages
English (en)
Inventor
Craig D Wegner
L Gordon Letts
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0507187T3 publication Critical patent/DK0507187T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1777—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
DK92105035.7T 1991-04-03 1992-03-24 Fremgangsmåde til hæmning af pulmonær oxygentoksicitet DK0507187T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67987091A 1991-04-03 1991-04-03

Publications (1)

Publication Number Publication Date
DK0507187T3 true DK0507187T3 (da) 1997-04-07

Family

ID=24728710

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92105035.7T DK0507187T3 (da) 1991-04-03 1992-03-24 Fremgangsmåde til hæmning af pulmonær oxygentoksicitet

Country Status (13)

Country Link
US (1) US5310551A (da)
EP (1) EP0507187B1 (da)
JP (1) JP3228548B2 (da)
AT (1) ATE145827T1 (da)
AU (1) AU655459B2 (da)
CA (1) CA2064604C (da)
DE (1) DE69215568T2 (da)
DK (1) DK0507187T3 (da)
ES (1) ES2094837T3 (da)
GR (1) GR3022578T3 (da)
HK (1) HK1003106A1 (da)
NZ (1) NZ242192A (da)
ZA (1) ZA922408B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
GB9115364D0 (en) 1991-07-16 1991-08-28 Wellcome Found Antibody
US5708141A (en) * 1992-05-11 1998-01-13 Corvas International, Inc. Neutrophil inhibitors
WO2019191128A1 (en) * 2018-03-26 2019-10-03 The United States Of America As Represented By The Secretary Of The Navy Use of tiotropium bromide to prevent pulmonary oxygen toxicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109123A (en) * 1988-06-14 1992-04-28 Dana Farber Cancer Institute Alteration of ability of soluble CD4 fragments to bind HIV
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
ATE79270T1 (de) * 1989-03-09 1992-08-15 Boehringer Ingelheim Pharma Verwendung von interzellularen adhaesionsmolek¨len und deren bindungsliganden bei der behandlung von asthma.

Also Published As

Publication number Publication date
DE69215568D1 (de) 1997-01-16
NZ242192A (en) 1997-06-24
EP0507187B1 (en) 1996-12-04
DE69215568T2 (de) 1997-05-15
AU1398692A (en) 1992-10-08
ATE145827T1 (de) 1996-12-15
JPH05255103A (ja) 1993-10-05
JP3228548B2 (ja) 2001-11-12
CA2064604A1 (en) 1992-10-04
ZA922408B (en) 1992-12-30
ES2094837T3 (es) 1997-02-01
CA2064604C (en) 2007-07-10
HK1003106A1 (en) 1998-10-09
AU655459B2 (en) 1994-12-22
GR3022578T3 (en) 1997-05-31
US5310551A (en) 1994-05-10
EP0507187A1 (en) 1992-10-07

Similar Documents

Publication Publication Date Title
DE69110785T3 (de) Narkosemittelverdampfer.
DE69232480T2 (de) Beatmungsgerät zur Erzeugung von kontinuierlichem positiven Atemwegdruck (CPAP)
TW263423B (da)
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
DE69525369D1 (de) Kontinuierliches polymerisationverfahren von polyamiden
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
DK0844869T3 (da) ULMWH (heparin med ultralav molekylvægt) til behandling af astma
DE3868127D1 (de) F-serien-prostaglandine.
DK0523315T3 (da) Gasblanding til bedøvelse bestående af xenon, oxygen og helium
DK0590271T3 (da) 17beta-aryl- og 17beta-heterocyclyl-5alfa, 14beta-androstan-, androsten- og -androstadienderivater med aktivitet på det kardiovaskulære system, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
TR199901772T2 (da)
DK0846173T3 (da) Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
DK0507187T3 (da) Fremgangsmåde til hæmning af pulmonær oxygentoksicitet
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
DK0476113T3 (da) Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose
DK0586589T3 (da) Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande
ATE121420T1 (de) Verfahren zur herstellung von 3-(l-pyroglutamyl)- l-thiazolidin-4-carbonsäure-derivaten.
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
DK0727219T3 (da) Medicinsk gasblanding
DK0679156T3 (da) Fremgangsmåde til fremstilling af 10-desacetoxybaccatin III og 10-desacetoxytaxol og derivater deraf
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ATE148991T1 (de) Nicotinamid-adenin-dinukleodid enthaltendes antidepressionsmittel
DK435089D0 (da) Anvendelse af zofenopril til behandling af rheumatoid arthritis
DK0458536T3 (da) Terapeutisk middel til behandling og forebyggelse af åndedrætsbesværsyndrom hos voksne
UA38888A (uk) Спосіб лікування хронічного вірусного гепатиту